Procaps Group Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Jose Antonio Vieira

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	n/a
Permanencia media de la dirección	5.4yrs
Promedio de permanencia en la Junta Directiva	1.4yrs

Actualizaciones recientes de la dirección

Recent updates

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Mar 28

CEO

Jose Antonio Vieira (58 yo)

less than a year

Permanencia

Mr. Jose Antonio Toledo Vieira is Chief Executive Officer of Procaps Group S.A. from January 15, 2024. He has been Member of Advisory Board at Patria Latin American Opportunity Acquisition Corp. since 2022...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Ruben Minski	Founder & Executive Chairman	no data	sin datos	27.78% $ 83.0m
Jose Antonio Vieira	Chief Executive Officer	less than a year	sin datos	sin datos
Patricio Munoz	Global Chief Financial Officer	2.8yrs	sin datos	sin datos
Camilo Camacho	Chief Operations Officer	no data	sin datos	sin datos
Melissa Angelini	Investor Relations Director	2.3yrs	sin datos	sin datos
Marcela Pagano	Vice-President of Corporate & Legal Affairs	11.4yrs	sin datos	sin datos
Luis Alberto Aragon	Vice-President of International Marketing and R&D	5.4yrs	sin datos	sin datos
Mauricio Caballero	Vice-President of Human Resources	9.8yrs	sin datos	sin datos
Carlos Russo	Head of Optimization of Corporate Value & Corporate VP of Finance	no data	sin datos	sin datos

5.4yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de PROC es experimentado (5.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Ruben Minski	Founder & Executive Chairman	no data	sin datos	27.78% $ 83.0m
Daniel Fink	Board Observer	1.3yrs	sin datos	sin datos
Jose Gontovnik	Director	no data	sin datos	15.92% $ 47.6m
Kyle Bransfield	Independent Director	2.8yrs	sin datos	1.81% $ 5.4m
David Yanovich Wancier	Independent Director	no data	sin datos	sin datos
Alberto Eguiguren Correa	Independent Director	1.4yrs	sin datos	sin datos
Luis Castro Vergara	Independent Director	no data	sin datos	sin datos
Sandra Sanchez Oldenhage	Independent Director	less than a year	sin datos	sin datos

1.4yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: La junta directiva de PROC no se considera experimentada (1.2 años de permanencia promedio), lo que sugiere una nueva junta directiva.

Procaps Group Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Procaps Group S.A., Annual General Meeting, Jun 30, 2023

Less than half of directors are independent

Recent updates

Procaps Group S.A. announced delayed 20-F filing

Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Investor sentiment deteriorates as stock falls 23%

Is Procaps Group S.A. (NASDAQ:PROC) Worth US$3.7 Based On Its Intrinsic Value?

New major risk - Revenue and earnings growth

Hoche Partners Sends a Letter to Procaps Group

Hoche Partners Sends a Letter to Procaps Group

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: US$0.08 (vs US$0.22 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Investor sentiment deteriorates as stock falls 17%

Procaps Group S.A. to Report Q3, 2023 Results on Nov 14, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 23%

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Investor sentiment deteriorates as stock falls 19%

Second quarter 2023 earnings released: EPS: US$0.27 (vs US$0.068 loss in 2Q 2022)

Procaps Group S.A. to Report Q2, 2023 Results on Sep 05, 2023

Procaps Group S.A., Annual General Meeting, Jun 30, 2023

Procaps Group S.A. to Report Q1, 2023 Results on Jun 05, 2023

Consensus EPS estimates fall by 28%

Full year 2022 earnings released: EPS: US$0.42 (vs US$1.03 loss in FY 2021)

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 15%

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Less than half of directors are independent

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. (NasdaqGM:PROC) announces an Equity Buyback for 2,000,000 shares, for $5 million.

Now 22% undervalued after recent price drop

Calculating The Intrinsic Value Of Procaps Group S.A. (NASDAQ:PROC)

Investor sentiment deteriorates as stock falls 16%

Procaps Group Announces Key Changes to the Board of Directors

Price target increased to US$13.00

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released

Procaps Group S.A. to Report Q3, 2022 Results on Nov 14, 2022

Now 22% undervalued after recent price drop

Now 23% undervalued after recent price drop

Second quarter 2022 earnings released: US$0.07 loss per share (vs US$0.01 loss in 2Q 2021)

Procaps Group reports Q2 results

Now 20% undervalued after recent price drop

First quarter 2022 earnings released: EPS: US$0.16 (vs US$0.18 loss in 1Q 2021)

Procaps Group S.A., Annual General Meeting, Jun 28, 2022

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Forecast to breakeven in 2022

Now 20% undervalued after recent price drop

Forecast to breakeven in 2022

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

Procaps Group, S.A. (NasdaqGM:PROC) acquired 86,000 sq. ft. Pharmaceutical Production Facility Located in West Palm Beach, Florida from Strides Pharma Inc.

Calculating The Fair Value Of Procaps Group, S.A. (NASDAQ:PROC)

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad